Literature DB >> 10037604

Resolution of a signal transfer region from a general binding domain in gbeta for stimulation of phospholipase C-beta2.

E Buck1, J Li, Y Chen, G Weng, S Scarlata, R Iyengar.   

Abstract

Signaling by guanine nucleotide-binding proteins (G proteins) involves sequential protein-protein interactions. G protein-betagamma subunit (Gbetagamma) interactions with phospholipase C-beta2 (PLC-beta2) were studied to determine if all Gbeta contacts are required for signaling. A peptide encoding Gbeta amino acid residues 86 to 105 stimulated PLC-beta2. Six residues (96 to 101) within this sequence could transfer signals and thus constitute a core signal transfer region. Another peptide, encoding Gbeta amino acid residues 115 to 135, did not substantially stimulate PLC-beta2 by itself but inhibited Gbetagamma stimulation, indicating that residues 115 to 135 constitute a general binding domain. Resolution of signal transfer regions from general binding domains indicates that all protein-protein contacts are not required for signal transfer and that it may be feasible to synthesize agonists and antagonists that regulate intracellular signal flow.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037604     DOI: 10.1126/science.283.5406.1332

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  13 in total

1.  Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules.

Authors:  Michael H A Roehrl; Sunghyun Kang; José Aramburu; Gerhard Wagner; Anjana Rao; Patrick G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-06       Impact factor: 11.205

Review 2.  Stimulation of phospholipase Cbeta by membrane interactions, interdomain movement, and G protein binding--how many ways can you activate an enzyme?

Authors:  Guillaume Drin; Suzanne Scarlata
Journal:  Cell Signal       Date:  2007-04-29       Impact factor: 4.315

3.  Evidence for a second, high affinity Gbetagamma binding site on Galphai1(GDP) subunits.

Authors:  Jingting Wang; Parijat Sengupta; Yuanjian Guo; Urszula Golebiewska; Suzanne Scarlata
Journal:  J Biol Chem       Date:  2009-04-15       Impact factor: 5.157

Review 4.  Structural insights into phospholipase C-β function.

Authors:  Angeline M Lyon; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2013-07-23       Impact factor: 4.436

Review 5.  G protein βγ subunits: central mediators of G protein-coupled receptor signaling.

Authors:  A V Smrcka
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

6.  Determination of the activation volume of PLCbeta by Gbeta gamma-subunits through the use of high hydrostatic pressure.

Authors:  Suzanne Scarlata
Journal:  Biophys J       Date:  2005-01-21       Impact factor: 4.033

7.  Hydrogen-bonding dynamics between adjacent blades in G-protein beta-subunit regulates GIRK channel activation.

Authors:  Tooraj Mirshahi; Diomedes E Logothetis; Avia Rosenhouse-Dantsker
Journal:  Biophys J       Date:  2006-01-20       Impact factor: 4.033

Review 8.  The correlation between multidomain enzymes and multiple activation mechanisms--the case of phospholipase Cβ and its membrane interactions.

Authors:  Harel Weinstein; Suzanne Scarlata
Journal:  Biochim Biophys Acta       Date:  2011-08-30

9.  Role of C-terminal domains of the G protein beta subunit in the activation of effectors.

Authors:  C S Myung; J C Garrison
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

10.  G protein-coupled receptor-mediated activation of p110β by Gβγ is required for cellular transformation and invasiveness.

Authors:  Hashem A Dbouk; Oscar Vadas; Aliaksei Shymanets; John E Burke; Rachel S Salamon; Bassem D Khalil; Mathew O Barrett; Gary L Waldo; Chinmay Surve; Christine Hsueh; Olga Perisic; Christian Harteneck; Peter R Shepherd; T Kendall Harden; Alan V Smrcka; Ronald Taussig; Anne R Bresnick; Bernd Nürnberg; Roger L Williams; Jonathan M Backer
Journal:  Sci Signal       Date:  2012-12-04       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.